Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation ; volume:6 ; number:1 ; day:21 ; month:10 ; year:2011 ; pages:1-7 ; date:12.2011
Radiation oncology ; 6, Heft 1 (21.10.2011), 1-7, 12.2011
- Creator
- Contributor
-
Berdel, Christian
Fleckenstein, Jochen
Licht, Norbert
Ketter, Ralf
Rübe, Christian
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-6-141
- URN
-
urn:nbn:de:1111-2016072615367
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Niewald, Marcus
- Berdel, Christian
- Fleckenstein, Jochen
- Licht, Norbert
- Ketter, Ralf
- Rübe, Christian
- SpringerLink (Online service)
Other Objects (12)
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Accelerated hyperfractionation plus temozolomide in glioblastoma
Effect of radiochemotherapy on peripheral immune response in glioblastoma
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Liver toxicity during temozolomide chemotherapy caused by Chinese herbs
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Accelerated hyperfractionation plus temozolomide in glioblastoma
Effect of radiochemotherapy on peripheral immune response in glioblastoma
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Liver toxicity during temozolomide chemotherapy caused by Chinese herbs
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Accelerated hyperfractionation plus temozolomide in glioblastoma
Effect of radiochemotherapy on peripheral immune response in glioblastoma
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Liver toxicity during temozolomide chemotherapy caused by Chinese herbs
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres